Moderna says dual variant booster with Beta more effective vs Omicron than current shot
The company said the results were a good sign for the company's plans for future shots targetting two COVID-19 variants
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved…
Canada authorises AstraZeneca’s drug for COVID prevention
The therapy has already been authorised in the US and its use has also been recommended by the European Medicines Agency (EMA)
Swissmedic grants conditional marketing authorisation to Nuvaxovid
The vaccine, also known as NVX-CoV2373, is the first protein-based vaccine to be authorised for use in Switzerland
Public complacency responsible for low uptake of booster dose of COVID vaccines: Experts
A booster shot as a precautionary dose helps increase protection against COVID-19 when protection from the initial vaccine dose…
Poorer nations shun millions of AstraZeneca COVID-19 vaccine doses
Countries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson…
Britain approves Valneva’s easy-to-store COVID shot
The shot is also the sixth COVID-19 vaccine to be approved in the UK
New COVID vaccine may provide protection for cancer patients
The results presented at the recent AACR Annual Meeting 2022, showed that the vaccine CoVac-1 induced T-cell immune responses in…
Britain widens access to Pfizer’s COVID anti-viral drug through trial
Paxlovid, a combination of Pfizer's new pill with an older anti-viral ritonavir, was made available to thousands of people with…
SII asks govt to reduce time gap for Covishield booster dose to six months
Adar Poonawalla, CEO, SII also pitched for a global pact for vaccine utilisation
Taiwan orders Pfizer’s COVID-19 pill amid rising infections
Chen Shih-chung, Health Minister, Taiwan, said the pills ordered would be enough to cover three per cent of Taiwan's population,…
Japan cancels a third of contracted Astrazeneca vaccine purchase
The contract allowed the government to cancel a portion of the supply if it was unneeded
Covaxin booster enhances antibody response against COVID variants: Study
The study was conducted in January and the findings were published in the "Journal of Travel Medicine" on 24th March
Precaution dose to be of same COVID vaccine, private centres can levy up to Rs 150 as service charge
The Centre announced that the precaution dose of COVID vaccines will be available to everyone aged above 18 years at the private…
Covaxin to cost Rs 225 per dose for private hospitals
Fresh stocks of Covaxin are available and ready for supplies
Centre okays booster doses for people aged above 18 years from 10th April, only at private centres
All those above the age of 18 years, who have taken their second dose more than nine months ago, will be eligible for the…
COVAX, African Union decline to buy more doses of Moderna’s COVID shots
Moderna and Gavi have agreements for up to 650 million doses of the company's vaccine to be made available to COVAX participants…
CanSinoBIO’s mRNA COVID-19 vaccine candidate cleared for clinical trials in China
Unlike other major countries, China is yet to approve any foreign-made mRNA vaccines such as that produced by American-German duo…
Government panel recommends Covovax inclusion in vaccine drive for those aged 12 and above
According to a source, a meeting of the COVID-19 Working Group was held on 1st April to review the data
US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults
If approved, Actemra/RoActemra would be the first US FDA-approved immunomodulator for the treatment of COVID-19 in hospitalised…